A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients

Supplemental digital content is available in the text. BACKGROUND Trauma-induced coagulopathy is a major driver of mortality following severe injury. Viscoelastic goal-directed resuscitation can reduce mortality after injury. The TEG 5000 system is widely used for viscoelastic testing. However, the TEG 6s system incorporates newer technology, with encouraging results in cardiovascular interventions. The purpose of this study was to validate the TEG 6s system for use in trauma patients. METHODS Multicenter noninvasive observational study for method comparison conducted at 12 US Levels I and II trauma centers. Agreement between the TEG 6s and TEG 5000 systems was examined using citrated kaolin reaction time (CK.R), citrated functional fibrinogen maximum amplitude (CFF.MA), citrated kaolin percent clot lysis at 30 minutes (CK.LY30), citrated RapidTEG maximum amplitude (CRT.MA), and citrated kaolin maximum amplitude (CK.MA) parameters in adults meeting full or limited trauma team criteria. Blood was drawn ≤1 hour after admission. Assays were repeated in duplicate. Reliability (TEG 5000 vs. TEG 6s analyzers) and repeatability (interdevice comparison) was quantified. Linear regression was used to define the relationship between TEG 6s and TEG 5000 devices. RESULTS A total of 475 patients were enrolled. The cohort was predominantly male (68.6%) with a median age of 49 years. Regression line slope estimates (ß) and linear correlation estimates (p) were as follows: CK.R (ß = 1.05, ρ = 0.9), CFF.MA (ß = 0.99, ρ = 0.95), CK.LY30 (ß = 1.01, ρ = 0.91), CRT.MA (TEG 6s) versus CK.MA (TEG 5000) (ß = 1.06, ρ = 0.86) as well as versus CRT.MA (TEG 5000) (ß = 0.93, ρ = 0.93), indicating strong reliability between the devices. Overall, within-device repeatability was better for TEG 6s versus TEG 5000, particularly for CFF.MA and CK.LY30. CONCLUSION The TEG 6s device appears to be highly reliable for use in trauma patients, with close correlation to the TEG 5000 device and equivalent/improved within-device reliability. Given the potential advantages of using the TEG 6s device at the site of care, confirmation of agreement between the devices represents an important advance in diagnostic testing. LEVEL OF EVIDENCE Diagnostic test, level II.

[1]  W. Voelckel,et al.  Comparison between the new fully automated viscoelastic coagulation analysers TEG 6s and ROTEM Sigma in trauma patients: A prospective observational study. , 2019, European journal of anaesthesiology.

[2]  J. Bamber,et al.  ROTEM® sigma reference range validity , 2019, Anaesthesia.

[3]  A. Sauaia,et al.  Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis , 2019, Journal of thrombosis and haemostasis : JTH.

[4]  R. Bellomo,et al.  Assessment of agreement and interchangeability between the TEG5000 and TEG6S thromboelastography haemostasis analysers: a prospective validation study , 2019, BMC Anesthesiology.

[5]  S. Stanworth,et al.  Towards patient‐specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry , 2019, Journal of thrombosis and haemostasis : JTH.

[6]  D. Fries,et al.  A comparison of the new ROTEM®sigma with its predecessor, the ROTEMdelta , 2018, Anaesthesia.

[7]  S. Morton,et al.  The practicalities and barriers of using TEG6s in code red traumas: an observational study in one London major trauma centre. , 2018, CJEM.

[8]  Matthew Miller,et al.  The reliability of thromboelastography in a simulated rotary wing environment , 2018, Emergency Medicine Journal.

[9]  M. A. Meledeo,et al.  Functional stability of the TEG 6s hemostasis analyzer under stress , 2018, The journal of trauma and acute care surgery.

[10]  N. Curzen,et al.  Detection of individual responses to clopidogrel: Validation of a novel, rapid analysis using thrombelastography 6s , 2018, Cardiovascular therapeutics.

[11]  Jeffrey T. Howard,et al.  Association of Prehospital Blood Product Transfusion During Medical Evacuation of Combat Casualties in Afghanistan With Acute and 30-Day Survival , 2017, JAMA.

[12]  R. Winfield,et al.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis? , 2017, Shock.

[13]  M. Gill.  The TEG®6s on Shaky Ground? A Novel Assessment of the TEG®6s Performance under a Challenging Condition. , 2017, The journal of extra-corporeal technology.

[14]  A. Sauaia,et al.  Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays , 2016, Annals of surgery.

[15]  P. Gurbel,et al.  First report of the point-of-care TEG: A technical validation study of the TEG-6S system , 2016, Platelets.

[16]  J. Sperry,et al.  Clinical assessment of trauma-induced coagulopathy and its contribution to postinjury mortality: A TACTIC proposal. , 2015, The journal of trauma and acute care surgery.

[17]  S. Mallett.  Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation , 2015, Seminars in Thrombosis & Hemostasis.

[18]  R. Schmicker,et al.  Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. , 2015, Annals of surgery.

[19]  David B Hoyt,et al.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.

[20]  C. Wade,et al.  Admission Rapid Thrombelastography Can Replace Conventional Coagulation Tests in the Emergency Department: Experience With 1974 Consecutive Trauma Patients , 2012, Annals of surgery.

[21]  S. Ellenberg.  Food and Drug Administration (FDA) , 2005 .

[22]  John A. Jones,et al.  Thromboelastography on-the-go: Evaluation of the TEG 6s device during ground and high-altitude Aeromedical Evacuation with extracorporeal life support. , 2019 .

[23]  E. Moore,et al.  Management of Trauma-Induced Coagulopathy with Thrombelastography. , 2017, Critical care clinics.